CRESCENDO BIOLOGICS
Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms. The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
CRESCENDO BIOLOGICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.crescendobiologics.com
Total Employee:
51+
Status:
Active
Contact:
441223467141
Email Addresses:
[email protected]
Total Funding:
116.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Biodiscovery V
Biodiscovery V investment in Series B - Crescendo Biologics
Sofinnova Partners
Sofinnova Partners investment in Series B - Crescendo Biologics
EMBL Ventures
EMBL Ventures investment in Series B - Crescendo Biologics
Quan Capital
Quan Capital investment in Series B - Crescendo Biologics
Takeda Ventures
Takeda Ventures investment in Series B - Crescendo Biologics
IP Group
IP Group investment in Series B - Crescendo Biologics
Andera Partners
Andera Partners investment in Series B - Crescendo Biologics
Astellas Venture Management
Astellas Venture Management investment in Venture Round - Crescendo Biologics
Sofinnova Partners
Sofinnova Partners investment in Series A - Crescendo Biologics
EMBL Ventures
EMBL Ventures investment in Series A - Crescendo Biologics
Official Site Inspections
http://www.crescendobiologics.com Semrush global rank: 6.27 M Semrush visits lastest month: 1.2 K
- Host name: 185-151-30-167.ptr4.stackcp.net
- IP address: 185.151.30.167
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London